Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Novanta's share price for the quarter that ended in Jun. 2026 was $162.99. Novanta's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 38 Mil. Therefore, Novanta's market cap for the quarter that ended in Jun. 2026 was $6,164 Mil.
Novanta's quarterly market cap
declined
from Dec. 2025 ($4,226 Mil) to Mar. 2026 ($4,067 Mil) but then
increased
from Mar. 2026 ($4,067 Mil) to Jun. 2026 ($6,164 Mil).
Novanta's annual market cap
declined
from Dec. 2023 ($6,098 Mil) to Dec. 2024 ($5,516 Mil) and
declined
from Dec. 2024 ($5,516 Mil) to Dec. 2025 ($4,226 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Novanta's Enterprise Value for Today is $5,865 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Novanta Market Cap Related Terms
Novanta Market Cap Historical Data
* Premium members only.
The historical data trend for Novanta's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Scientific & Technical Instruments subindustry, Novanta's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novanta Market Cap vs Hardware Industry
For the Hardware industry and Technology sector, Novanta's Market Cap distribution charts can be found below:
* The bar in red indicates where Novanta's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Novanta's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novanta (LTS:0VAG) has a Market Cap of $6,299 Mil as of Aug. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Novanta and its competitors. According to the industry distribution chart, Novanta ranks #185 out of 2517 companies in the Hardware industry, placing it in the top 7.4%.
Is Novanta's Market Cap too high?
Novanta's current Market Cap is $6,299 Mil. The Hardware industry median Market Cap is 210.75. Novanta's value of $6,299 Mil is 2888.9% above this industry median. Based on the distribution chart, Novanta ranks #185 out of 2517 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Novanta has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novanta's Market Cap compare to VNT and ITRI?
According to the Hardware industry distribution chart, Novanta ranks #185 out of 2517 companies for Market Cap. This places Novanta in the top 7% of its industry — outperforming the majority of peers. The industry median Market Cap is 210.75. Novanta's value of $6,299 Mil is 2888.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Hardware company?
The median Market Cap among Hardware companies is 210.75, based on 2,517 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novanta's current Market Cap of $6,299 Mil is 2888.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Novanta and its competitors. For the Hardware industry, the median Market Cap is 210.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novanta's current Market Cap is $6,299 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novanta stock overvalued right now?
Based on GuruFocus' analysis, Novanta (LTS:0VAG) is currently considered Fairly Valued. The stock's GF Value™ is $154.36, compared to a current price of $167.00 — trading 8.2% above its estimated fair value. The current Market Cap is $6,299 Mil and 2888.9% above the Hardware industry median of 210.75. Novanta's overall GF Score™ is 91/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Novanta (LTS:0VAG), the current Market Cap is $6,299 Mil as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novanta (LTS:0VAG) Overvalued in 2026?
Based on GuruFocus' analysis, Novanta stock appears to be overvalued.
The current stock price of $167.00 is trading 8.2% above its estimated GF Value™ of $154.36.
GuruFocus considers Novanta to be Fairly Valued.
Key valuation signals for LTS:0VAG:
Market Cap: $6,299 Mil
GF Value™: $154.36 vs. price of $167.00 (8.2% above fair value)
Industry Position: 2888.9% above the Hardware median (#185 of 2517)
No single metric tells the full story. See the LTS:0VAG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
91GF Score
Get the complete analysis for LTS:0VAG
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0VAG has been successfully added to your 
